Merdury Biopharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	80.49	53.17	68.01	44.29	31.94	2.56
Short-Term Investments	56	110.6	162.8	284.78	108.7	-
Cash & Short-Term Investments	136.49	163.77	230.81	329.07	140.64	2.56
Cash Growth	-31.38%	-29.05%	-29.86%	133.99%	5391.45%	2877.91%
Other Receivables	0.3	6.38	4.73	0.23	2.46	-
Receivables	0.3	6.38	4.73	0.23	2.46	-
Prepaid Expenses	-	4.25	7.18	10.07	2.64	-
Other Current Assets	12.97	0.36	0.18	0.55	-	1.37
Total Current Assets	151.97	174.76	242.9	339.93	145.73	3.93
Property, Plant & Equipment	89.84	89.75	94.41	79.94	75.15	8.46
Other Intangible Assets	4.71	5.45	4.53	2.71	0.5	0.49
Other Long-Term Assets	13.37	8.44	11.37	15.5	8.55	0.51
Total Assets	259.89	278.39	353.2	438.08	229.93	13.38
Accrued Expenses	-	7.99	7.21	-	4.61	0.66
Current Portion of Long-Term Debt	2.14	2.12	1.21	-	-	-
Current Portion of Leases	1.13	0.73	2.6	0.68	1.05	0.79
Current Unearned Revenue	5.79	5.79	5.48	0.44	-	-
Other Current Liabilities	8.59	3.14	2.73	6.93	1.57	0.26
Total Current Liabilities	19.58	19.77	19.24	8.05	7.23	1.7
Long-Term Debt	37.02	38.1	40.39	41.6	41.6	-
Long-Term Leases	2.52	0.85	3.31	0.07	0.77	1.22
Total Liabilities	59.12	58.72	62.93	49.72	49.6	2.93
Common Stock	108.15	106.74	105.46	103.99	100.87	15.4
Additional Paid-In Capital	-	244.5	291.29	328.17	110.72	0.37
Retained Earnings	-22.71	-67.23	-50.57	-43.82	-31.25	-5.31
Treasury Stock	-64.81	-64.81	-56.24	-	-	-
Comprehensive Income & Other	180.14	0.46	0.33	0.01	-	-
Shareholders' Equity	200.77	219.67	290.27	388.35	180.33	10.46
Total Liabilities & Equity	259.89	278.39	353.2	438.08	229.93	13.38
Total Debt	42.8	41.79	47.51	42.35	43.42	2.01
Net Cash (Debt)	93.69	121.98	183.3	286.73	97.21	0.55
Net Cash Growth	-38.39%	-33.45%	-36.07%	194.94%	17575.09%	-
Net Cash Per Share	0.22	0.29	0.44	0.72	0.26	0.00
Filing Date Shares Outstanding	454.2	422.03	421.85	415.96	403.46	403.46
Total Common Shares Outstanding	454.2	422.03	421.85	415.96	403.46	307.94
Working Capital	132.39	154.99	223.66	331.88	138.5	2.22
Book Value Per Share	0.44	0.52	0.69	0.93	0.45	0.03
Tangible Book Value	196.07	214.22	285.75	385.65	179.83	9.97
Tangible Book Value Per Share	0.43	0.51	0.68	0.93	0.45	0.03
Land	-	41.9	41.9	-	41.9	-
Buildings	-	18.2	18.27	-	18.12	-
Machinery	-	34.42	23.45	-	6.42	5.88
Construction In Progress	-	7.29	11.59	-	7.5	-
Leasehold Improvements	-	2.36	2.33	-	0.91	0.91